Collegium Pharmaceutical, Inc. (COLL)

NASDAQ: COLL · Real-Time Price · USD

33.65

-0.13 (-0.38%)

At close: May 18, 2026, 4:00 PM EDT

33.85

+0.20 (0.59%)

After-hours: May 18, 2026, 4:47 PM EDT

Collegium Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	268.65	231.25	70.57	238.95	173.69	186.43
Short-Term Investments	153.11	155.43	92.2	71.6	-	-
Cash & Short-Term Investments	421.75	386.68	162.76	310.55	173.69	186.43
Cash Growth	113.25%	137.57%	-47.59%	78.80%	-6.83%	7.07%
Accounts Receivable	228.76	211.33	228.54	179.53	183.12	105.84
Inventory	42.74	40.91	35.56	32.33	46.5	17.39
Other Current Assets	52.41	52.49	55.39	15.2	16.68	5.88
Total Current Assets	745.67	691.41	482.26	537.6	419.99	315.54
Net Property, Plant & Equipment	15.64	16.2	20.15	22.01	26.38	27.14
Other Intangible Assets	614.04	669.51	891.4	421.71	567.47	268.72
Goodwill	145.93	145.93	162.33	133.86	133.7	-
Other Long-Term Assets	130.69	133.79	107.45	28.13	26.6	80.68
Total Assets	1,652	1,657	1,664	1,143	1,174	692.08
Accounts Payable	6.83	10.66	3.93	8.69	3.49	4.19
Accrued Expenses	375.84	380.73	410.77	264.9	266.62	226.21
Current Portion of Long-Term Debt	32.63	29	64.58	183.33	162.5	48.35
Current Portion of Leases	1.45	1.41	1.27	0.99	1.11	0.81
Unearned Revenue	0.67	0.67	-	-	-	-
Other Current Liabilities	17.57	17.57	28.96	-	-	-
Total Current Liabilities	434.97	440.03	509.51	457.92	433.73	279.57
Long-Term Debt	891.83	901.89	908.52	483.84	538.45	201.63
Long-Term Leases	3.79	4.13	5.54	6.12	7.11	7.95
Other Long-Term Liabilities	8.94	9.11	11.18	-	-	-
Total Long-Term Liabilities	904.56	915.13	925.24	489.96	545.56	209.58
Total Liabilities	1,340	1,355	1,435	947.88	979.29	489.15
Common Stock	0.04	0.04	0.04	0.04	0.04	0.04
Treasury Stock	-222.51	-222.51	-197.51	-137.38	-61.92	-42.86
Additional Paid-in Capital	621.74	624.95	590.25	565.95	538.07	502.1
Accumulated Other Comprehensive Income	-0.22	0.32	0.06	0.01	-	-
Retained Earnings	-86.63	-101.13	-164	-233.19	-281.34	-256.34
Shareholders' Equity	312.42	301.68	228.84	195.43	194.84	202.93
Total Liabilities & Equity	1,652	1,657	1,664	1,143	1,174	692.08
Total Debt	929.69	936.43	979.91	674.28	709.18	258.75
Net Cash (Debt)	-507.94	-549.75	-817.15	-363.74	-535.49	-72.32
Net Cash Per Share	-12.81	-13.85	-20.21	-8.70	-15.83	-1.76
Book Value	312.42	301.68	228.84	195.43	194.84	202.93
Book Value Per Share	7.88	7.60	5.66	4.68	5.76	4.94
Tangible Book Value	-447.54	-513.76	-824.89	-360.13	-506.32	-65.8
Tangible Book Value Per Share	-11.28	-12.94	-20.41	-8.62	-14.97	-1.60

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q